These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8682488)
1. Extracellular matrix proteins and hepatic fibrosis. Johnson SJ Hepatogastroenterology; 1996; 43(7):44-55. PubMed ID: 8682488 [No Abstract] [Full Text] [Related]
2. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells. Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutical targets for revert liver fibrosis]. García B L; Gálvez G J; Armendáriz B J Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907 [TBL] [Abstract][Full Text] [Related]
4. Hepatic progenitor cell-mediated regeneration and fibrosis: chicken or egg? Clouston AD; Jonsson JR; Powell EE Hepatology; 2009 May; 49(5):1424-6. PubMed ID: 19399908 [No Abstract] [Full Text] [Related]
6. Liver extracellular matrix in health and disease. Bedossa P; Paradis V J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618 [TBL] [Abstract][Full Text] [Related]
7. Experimental hepatic fibrosis without hepatocellular regeneration. A kinetic study. Rubin E; Hutterer F; Popper H Am J Pathol; 1968 Jan; 52(1):111-20. PubMed ID: 5694034 [No Abstract] [Full Text] [Related]
8. Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types. Saile B; Ramadori G Z Gastroenterol; 2007 Jan; 45(1):77-86. PubMed ID: 17236124 [TBL] [Abstract][Full Text] [Related]
9. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564 [TBL] [Abstract][Full Text] [Related]
10. Role of Ito cells in the liver function. Flisiak R Pol J Pathol; 1997; 48(3):139-45. PubMed ID: 9401406 [TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrosis: can we treat it clinically? Das K; Chowdhury A Trop Gastroenterol; 2008; 29(2):76-83. PubMed ID: 18972766 [TBL] [Abstract][Full Text] [Related]
13. [Lhx2 seems to inhibit the development of liver cirrhosis. Gene discovery makes the development of drugs against this enormous health problem possible]. Carlsson L; Danielsson A Lakartidningen; 2006 May 17-30; 103(20):1594-7. PubMed ID: 16800084 [No Abstract] [Full Text] [Related]
14. Liver fibrosis: from the bench to clinical targets. Pinzani M; Rombouts K Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333 [TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells and the reversal of fibrosis. Kisseleva T; Brenner DA J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681 [TBL] [Abstract][Full Text] [Related]
16. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Elsharkawy AM; Oakley F; Mann DA Apoptosis; 2005 Oct; 10(5):927-39. PubMed ID: 16151628 [TBL] [Abstract][Full Text] [Related]
17. Genesis of hepatic fibrosis and its biochemical markers. Das SK; Vasudevan DM Scand J Clin Lab Invest; 2008; 68(4):260-9. PubMed ID: 18609066 [TBL] [Abstract][Full Text] [Related]
18. Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype. Kawada N Methods Mol Med; 2005; 117():371-9. PubMed ID: 16118463 [TBL] [Abstract][Full Text] [Related]